{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:28:25Z","timestamp":1763728105886},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cholestasis might lead to an impairment of adrenal function as suggested by in vitro and in vivo data as well as by clinical findings. Bile acid and adrenal steroid metabolism not only share the receptors farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (TGR5), but supraphysiological bile acid levels were found to stimulate steroidogenesis independent of FXR and TGR5. Our previous experimental findings revealed that mice fed bile acids or subjected to common bile duct ligation develop hypercortisolemia. We thus aimed to assess adrenal gland function in patients with cholestasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Adrenal gland function was assessed in 36 patients with cholestasis and in 32 patients without cholestasis by measuring total serum cortisol, adrenocorticotropic hormone (ACTH), as well as the increase of cortisol 20 and 30\u00a0min after administration of 1\u00a0\u00b5g of ACTH. Bile acid levels and bile acid pool composition were determined by high-resolution mass spectrometry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients with cholestasis per definition had markedly elevated levels of alkaline phosphatase (AP), bilirubin and serum bile acids. Baseline cortisol and maximum cortisol after ACTH stimulation were significantly higher in patients with cholestasis compared to controls. Increase of cortisol after ACTH stimulation and ACTH did not differ. In the cholestasis group, baseline cortisol correlated with bilirubin but not with AP, total serum bile acids and levels of conjugated and unconjugated bile acid species. Patients with duration of cholestasis\u2009&lt;\u20096\u00a0months (n\u2009=\u200930) had significantly higher baseline cortisol levels than those with long standing cholestasis (&gt;\u20096\u00a0months), together with higher bilirubin levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We find no evidence of adrenal insufficiency in non-cirrhotic patients with cholestasis. In contrast, patients with cholestasis show hypercortisolism associated with disease severity as mirrored by levels of bilirubin. Lack of ACTH increase in cholestasis suggests a direct effect of cholestasis on adrenals and not on the pituitary gland. Further studies are needed to elucidate the mechanism of cortisol elevation in patients with cholestasis and its clinical significance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-021-02045-4","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T12:03:26Z","timestamp":1638878606000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hypercortisolism in patients with cholestasis is associated with disease severity"],"prefix":"10.1186","volume":"21","author":[{"given":"Verena","family":"Theiler-Schwetz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansj\u00f6rg","family":"Schlager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Obermayer-Pietsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Stojakovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Fauler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Fickert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Zollner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"issue":"1","key":"2045_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2007.11.010","volume":"12","author":"G Zollner","year":"2008","unstructured":"Zollner G, Trauner M. Mechanisms of cholestasis. Clin Liver Dis. 2008;12(1):1\u201326 (vii).","journal-title":"Clin Liver Dis"},{"issue":"9","key":"2045_CR2","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/liv.13880","volume":"38","author":"J Goldstein","year":"2018","unstructured":"Goldstein J, Levy C. Novel and emerging therapies for cholestatic liver diseases. Liver Int. 2018;38(9):1520\u201335.","journal-title":"Liver Int"},{"issue":"7","key":"2045_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/sj.emboj.7601049","volume":"25","author":"SM Houten","year":"2006","unstructured":"Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids. EMBO J. 2006;25(7):1419\u201325.","journal-title":"EMBO J"},{"issue":"1","key":"2045_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00010.2008","volume":"89","author":"P Lefebvre","year":"2009","unstructured":"Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev. 2009;89(1):147\u201391.","journal-title":"Physiol Rev"},{"issue":"4 Pt B","key":"2045_CR5","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.bbadis.2017.08.021","volume":"1864","author":"K Deutschmann","year":"2018","unstructured":"Deutschmann K, Reich M, Klindt C, Droge C, Spomer L, Haussinger D, Keitel V. Bile acid receptors in the biliary tree: TGR5 in physiology and disease. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4 Pt B):1319\u201325.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2045_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","volume":"39","author":"JYL Chiang","year":"2019","unstructured":"Chiang JYL, Ferrell JM. Bile acids as metabolic regulators and nutrient sensors. Annu Rev Nutr. 2019;39:175\u2013200.","journal-title":"Annu Rev Nutr"},{"issue":"4","key":"2045_CR7","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/hep.28991","volume":"65","author":"M Trauner","year":"2017","unstructured":"Trauner M, Fuchs CD, Halilbasic E, Paumgartner G. New therapeutic concepts in bile acid transport and signaling for management of cholestasis. Hepatology. 2017;65(4):1393\u2013404.","journal-title":"Hepatology"},{"issue":"1","key":"2045_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.bbadis.2018.08.001","volume":"1865","author":"V Theiler-Schwetz","year":"2019","unstructured":"Theiler-Schwetz V, Zaufel A, Schlager H, Obermayer-Pietsch B, Fickert P, Zollner G. Bile acids and glucocorticoid metabolism in health and disease. Biochim Biophys Acta Mol Basis Dis. 2019;1865(1):243\u201351.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"2045_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1074\/jbc.M209505200","volume":"278","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Kast-Woelbern HR, Edwards PA. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. J Biol Chem. 2003;278(1):104\u201310.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"2045_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mce.2012.05.010","volume":"362","author":"M Hoekstra","year":"2012","unstructured":"Hoekstra M, van der Sluis RJ, Li Z, Oosterveer MH, Groen AK, Van Berkel TJ. FXR agonist GW4064 increases plasma glucocorticoid levels in C57BL\/6 mice. Mol Cell Endocrinol. 2012;362(1\u20132):69\u201375.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2045_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.mce.2008.11.006","volume":"299","author":"Y Xing","year":"2009","unstructured":"Xing Y, Saner-Amigh K, Nakamura Y, Hinshelwood MM, Carr BR, Mason JI, Rainey WE. The farnesoid X receptor regulates transcription of 3beta-hydroxysteroid dehydrogenase type 2 in human adrenal cells. Mol Cell Endocrinol. 2009;299(2):153\u201362.","journal-title":"Mol Cell Endocrinol"},{"key":"2045_CR12","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1111\/liv.14052","volume":"39","author":"L Liu","year":"2019","unstructured":"Liu L, Panzitt K, Racedo S, Wagner M, Platzer W, Zaufel A, Theiler-Schwetz V, Obermayer-Pietsch B, Muller H, Hofler G, Heinemann A, Zollner G, Fickert P. Bile acids increase steroidogenesis in cholemic mice and induce cortisol secretion in adrenocortical H295R cells via S1PR2, ERK and SF-1. Liver Int. 2019;39:2112\u201323.","journal-title":"Liver Int"},{"issue":"6","key":"2045_CR13","first-page":"1016","volume":"39","author":"RM Zollinger","year":"1956","unstructured":"Zollinger RM, Williams RD. Surgical aspects of jaundice. Surgery. 1956;39(6):1016\u201330.","journal-title":"Surgery"},{"key":"2045_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/archsurg.1960.01300020162022","volume":"81","author":"RD Williams","year":"1960","unstructured":"Williams RD, Elliott DW, Zollinger RM. The effect of hypotension in obstructive jaundice. Arch Surg. 1960;81:334\u201340.","journal-title":"Arch Surg"},{"issue":"5","key":"2045_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jhep.2009.10.037","volume":"52","author":"AD McNeilly","year":"2010","unstructured":"McNeilly AD, Macfarlane DP, O\u2019Flaherty E, Livingstone DE, Mitic T, McConnell KM, McKenzie SM, Davies E, Reynolds RM, Thiesson HC, Skott O, Walker BR, Andrew R. Bile acids modulate glucocorticoid metabolism and the hypothalamic\u2013pituitary\u2013adrenal axis in obstructive jaundice. J Hepatol. 2010;52(5):705\u201311.","journal-title":"J Hepatol"},{"issue":"3","key":"2045_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0168-8278(01)00152-0","volume":"35","author":"B Zietz","year":"2001","unstructured":"Zietz B, Wengler I, Messmann H, Lock G, Scholmerich J, Straub RH. Early shifts of adrenal steroid synthesis before and after relief of short-term cholestasis. J Hepatol. 2001;35(3):329\u201337.","journal-title":"J Hepatol"},{"issue":"3","key":"2045_CR17","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/hep.21741","volume":"46","author":"T Stojakovic","year":"2007","unstructured":"Stojakovic T, Putz-Bankuti C, Fauler G, Scharnagl H, Wagner M, Stadlbauer V, Gurakuqi G, Stauber RE, Marz W, Trauner M. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology. 2007;46(3):776\u201384.","journal-title":"Hepatology"},{"key":"2045_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cca.2016.11.014","volume":"464","author":"B Amplatz","year":"2017","unstructured":"Amplatz B, Zohrer E, Haas C, Schaffer M, Stojakovic T, Jahnel J, Fauler G. Bile acid preparation and comprehensive analysis by high performance liquid chromatography-high-resolution mass spectrometry. Clin Chim Acta. 2017;464:85\u201392.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"2045_CR19","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(5):1526\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2045_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364\u201389.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2045_CR21","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/hep.25573","volume":"55","author":"G Fede","year":"2012","unstructured":"Fede G, Spadaro L, Tomaselli T, Privitera G, Germani G, Tsochatzis E, Thomas M, Bouloux PM, Burroughs AK, Purrello F. Adrenocortical dysfunction in liver disease: a systematic review. Hepatology. 2012;55(4):1282\u201391.","journal-title":"Hepatology"},{"issue":"3","key":"2045_CR22","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cgh.2013.08.028","volume":"12","author":"G Fede","year":"2014","unstructured":"Fede G, Spadaro L, Tomaselli T, Privitera G, Scicali R, Vasianopoulou P, Thalassinos E, Martin N, Thomas M, Purrello F, Burroughs AK. Comparison of total cortisol, free cortisol, and surrogate markers of free cortisol in diagnosis of adrenal insufficiency in patients with stable cirrhosis. Clin Gastroenterol Hepatol. 2014;12(3):504-12.e8 (quiz e23-4).","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"2045_CR23","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/hep.26535","volume":"58","author":"J Acevedo","year":"2013","unstructured":"Acevedo J, Fernandez J, Prado V, Silva A, Castro M, Pavesi M, Roca D, Jimenez W, Gines P, Arroyo V. Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death. Hepatology. 2013;58(5):1757\u201365.","journal-title":"Hepatology"},{"issue":"12","key":"2045_CR24","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1097\/CCM.0000000000002737","volume":"45","author":"D Annane","year":"2017","unstructured":"Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A, Briegel J, Carcillo J, Christ-Crain M, Cooper MS, Marik PE, Umberto Meduri G, Olsen KM, Rodgers SC, Russell JA, Van den Berghe G. Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med. 2017;45(12):2078\u201388.","journal-title":"Crit Care Med"},{"issue":"3","key":"2045_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/hep.510300303","volume":"30","author":"D Ackermann","year":"1999","unstructured":"Ackermann D, Vogt B, Escher G, Dick B, Reichen J, Frey BM, Frey FJ. Inhibition of 11beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis. Hepatology. 1999;30(3):623\u20139.","journal-title":"Hepatology"},{"key":"2045_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev.bi.44.070175.001313","volume":"44","author":"H Danielsson","year":"1975","unstructured":"Danielsson H, Sjovall J. Bile acid metabolism. Annu Rev Biochem. 1975;44:233\u201353.","journal-title":"Annu Rev Biochem"},{"issue":"8618","key":"2045_CR27","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","volume":"2","author":"CR Edwards","year":"1988","unstructured":"Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase\u2013tissue specific protector of the mineralocorticoid receptor. Lancet. 1988;2(8618):986\u20139.","journal-title":"Lancet"},{"issue":"4","key":"2045_CR28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/hep.21381","volume":"44","author":"FJ Frey","year":"2006","unstructured":"Frey FJ. Impaired 11 beta-hydroxysteroid dehydrogenase contributes to renal sodium avidity in cirrhosis: hypothesis or fact? Hepatology. 2006;44(4):795\u2013801.","journal-title":"Hepatology"},{"issue":"1","key":"2045_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0016-5085(98)70645-6","volume":"114","author":"G Escher","year":"1998","unstructured":"Escher G, Nawrocki A, Staub T, Vishwanath BS, Frey BM, Reichen J, Frey FJ. Down-regulation of hepatic and renal 11 beta-hydroxysteroid dehydrogenase in rats with liver cirrhosis. Gastroenterology. 1998;114(1):175\u201384.","journal-title":"Gastroenterology"},{"issue":"2","key":"2045_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1530\/eje.0.1420200","volume":"142","author":"S Diederich","year":"2000","unstructured":"Diederich S, Grossmann C, Hanke B, Quinkler M, Herrmann M, Bahr V, Oelkers W. In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I. Eur J Endocrinol. 2000;142(2):200\u20137.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2045_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.metabol.2003.12.027","volume":"53","author":"DJ Morris","year":"2004","unstructured":"Morris DJ, Souness GW, Latif SA, Hardy MP, Brem AS. Effect of chenodeoxycholic acid on 11beta-hydroxysteroid dehydrogenase in various target tissues. Metabolism. 2004;53(6):811\u20136.","journal-title":"Metabolism"},{"issue":"4","key":"2045_CR32","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/med.21660","volume":"40","author":"L Vitek","year":"2020","unstructured":"Vitek L. Bilirubin as a signaling molecule. Med Res Rev. 2020;40(4):1335\u201351.","journal-title":"Med Res Rev"},{"issue":"2","key":"2045_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1515\/jpem-2017-0270","volume":"31","author":"KC Verbeeten","year":"2018","unstructured":"Verbeeten KC, Ahmet AH. The role of corticosteroid-binding globulin in the evaluation of adrenal insufficiency. J Pediatr Endocrinol Metab. 2018;31(2):107\u201315.","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-02045-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-021-02045-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-02045-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T12:10:20Z","timestamp":1638879020000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-021-02045-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2045"],"URL":"https:\/\/doi.org\/10.1186\/s12876-021-02045-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"30 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients gave written informed consent prior to inclusion and were older than 18\u00a0years. The study was approved by the Research Ethics Board of the Medical University of Graz (ethics board approval #26-163 ex 13\/14). All study procedures were performed according to the Declaration of Helsinki and Good Clinical Practice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"460"}}